Company

Pleco Therapeutics aims to extend the life span and enhance the quality of life of patients through its novel Plecoid™ therapies that dramatically increase the effectiveness of current cancer treatments. 

Pleco Therapeutics’ mission is to demonstrate the market value and therapeutic potential of our proprietary Plecoid™ products through an initial focus on treatments for orphan cancers.  Thereafter we can expand our scalable fixed-dose combination platform for the treatment of other cancers as well as neurodegenerative disorders where aberrant metal patterns have been shown to play a role.

Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.

Pleco Therapeutics BV
Jonkerbosplein 52
6534 AB Nijmegen
The Netherlands

info@plecotherapeutics.com
+31 611 325 510

www.plecotherapeutics.com 

 

 

More companies in this area

GCP-Service International

GCP-Service International is a mid-size contract research organization (CRO), with branches across Germany, Netherlands, Poland and Czech Republic.

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,

Vaxxinova

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.

TropIQ

TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!